Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing emphasis on preventive health screening
3.2.1.2 Advances in cellular health testing technologies
3.2.1.3 Growing demand for personalized medicine
3.2.1.4 Rising demand for direct-to-consumer screening kits
3.2.2 Industry pitfalls & challenges
3.2.2.1 Limited reimbursement coverage
3.2.2.2 Lack of standardization
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Future market trends
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Test Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Single test panels
5.2.1 Telomere tests
5.2.2 Oxidative stress tests
5.2.3 Inflammation tests
5.2.4 Heavy metals tests
5.3 Multi-test panels
Chapter 6 Market Estimates and Forecast, By Sample Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Blood samples
6.3 Saliva samples
6.4 Serum samples
6.5 Urine samples
Chapter 7 Market Estimates and Forecast, By Collection Site, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 At-home
7.3 In-office
7.4 Hospitals
7.5 Diagnostic laboratories
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Atomo Diagnostics
9.2 Cell Science Systems
9.3 Cleveland HeartLab, Inc.
9.4 DNA Labs India
9.5 Genova Diagnostics
9.6 GRAIL, Inc.
9.7 Immundiagnostik AG
9.8 Laboratory Corporation of America Holdings
9.9 OmegaQuant
9.10 OPKO Health, Inc.
9.11 Quest Diagnostics Inc.
9.12 RepeatDx
9.13 Segterra, Inc.
9.14 SpectraCell Laboratories
9.15 Telomere Diagnostics, Inc.
